HATFIELD, England, November 6, 2014 /PRNewswire/ -- Eisai announces with utmost disappointment that the German Federal Joint Committee (G-BA) has decided that the additional benefit for new generation anti-epileptic drug (AED) Fycompa (perampanel) has not been proven, when compared to conventional AEDs as defined by the G-BA.[1] The decision, based on methodological rather than clinical considerations, ignores the demands of the German Epilepsy Association (DE) and other epilepsy patient advocacy groups to recognise the additional benefit seen in practical applications as well as in studies.[2] The decision also ignores the recommendations of the German Society of Epileptology (DGfE) to assess the additional benefit of new AEDs. The efficacy and tolerability of adjunctive perampanel in the treatment of partial onset seizures in real world clinical practice has been demonstrated by a multi-centre, six-month observational study from nine epilepsy centres in Germany and Austria. The results show that half of the 281 people with highly refractory epilepsy treated with perampanel experienced at least a 50% reduction in seizure frequency and up to 15% became seizure free during the observation period.[3] "We are utterly disappointed by the decision of the German Joint Federal Committee (G-BA) not to recognise the additional benefit of perampanel … Continue reading →

Donna Simon Leads Roundtable Discussion on Autism Assemblywoman Donna Simon hosted a roundtable on Oct. 30 in Flemington to discuss insurance, housing, education and employment issues faced by the autism community. Simon is sponsor of ... By: NJ Assembly Republicans … Continue reading →

SOURCE: Kirkman Group, Inc. RENO, NV--(Marketwired - November 06, 2014) - Research is zeroing in on the connection between the gut and the brain, especially in the area of autism.Autism Speaks just announced that itwillprovide $2.3 million to fund two major research studies to advance this understanding -- one focused on intestinal bacteria, the other on chronic constipation. "Ten years ago, when a child with autism had a gastrointestinal issue -- they were sent to a behaviorist, psychologist or neurologist," David Humphrey, CEO of Kirkman Group, a nutritional supplement company, said. Humphrey started the Autism Treatment Network (ATN) in 2005 because of the difficultly that his customers had in getting medical treatment for their children diagnosed with autism -- especially if they had intense and pervasive gastrointestinal (GI) issues. It took awhile, but thanks to the tenacious work of Autism Speaks that took over ATN in 2009, most physicians now recognize that children diagnosed with autism may have comorbid medical conditions, the most common of which are gastrointestinal diseases. ATN funded several important studies about gastrointestinal issues and autism.New studies are pointing to inflammation, particularly in the gut, as a significant factor in the cause of autism spectrum disorder (ASD) … Continue reading →

Enter Google and its seemingly limitless computing capacity. About a year and a half ago, David Glazer, a Google engineering director in search for a new challenge, formed a team within the company to find life-science projects that could benefit from using its cloud platform, which was designed to store and analyze massive data sets. Autism Speaks, which had already been collecting genomes from patients and their families for 15 years, seemed the perfect fit. "Part of Google's business is to make our cloud platform useful and available to anyone who has hard, scalable information and data problems to solve," Glazer said. But "until fairly recently, a biologist didn't need a tool more powerful than Excel to work with all the data that they were able to gather. That's changed, particularly with the advent of genomics and genomic sequencing. "This is a tremendous opportunity to really put our platform to use," he added, "and, of course, being a great customer for our platform." Read MoreEntrepreneurship the answer for some with autism That the lead researcher for Google's first life-science client should be Dr. Scherer makes some historical sense. His signature work greatly contributed to the massive increase in data now … Continue reading →

Enter Google and its seemingly limitless computing capacity. About a year and a half ago, David Glazer, a Google engineering director in search for a new challenge, formed a team within the company to find life-science projects that could benefit from using its cloud platform, which was designed to store and analyze massive data sets. Autism Speaks, which had already been collecting genomes from patients and their families for 15 years, seemed the perfect fit. "Part of Google's business is to make our cloud platform useful and available to anyone who has hard, scalable information and data problems to solve," Glazer said. But "until fairly recently, a biologist didn't need a tool more powerful than Excel to work with all the data that they were able to gather. That's changed, particularly with the advent of genomics and genomic sequencing. "This is a tremendous opportunity to really put our platform to use," he added, "and, of course, being a great customer for our platform." Read MoreEntrepreneurship the answer for some with autism That the lead researcher for Google's first life-science client should be Dr. Scherer makes some historical sense. His signature work greatly contributed to the massive increase in data now … Continue reading →

Jhansi Best Paralysis Treatment by Dr. Dassan Ayurveda Center Dr.Dassan's life Care Ayurvedic Herbal Treatment and Research Centre Treats patients with tested Ayurvedic Medicines which do not produce any side effects Dr.Dassan's Ayurvedic Herbal Centre... By: Brain Stroke Treatment … Continue reading →

One out of six people will suffer from a stroke in their lifetime. The attack cuts off vital blood flow and oxygen to the brain, which can kill two million brain cells in just 60 seconds. But despite this threat, few Americans know how to prevent and treat a stroke. Dr. Manny Alvarez, senior managing health editor of FoxNews.com, recently sat down with cardiologist Mark Turco, the chief medical officer at Covidien Vascular Therapies to talk about stroke awareness. Turco teamed up with the World Stroke Organization and its global "Take 2Tell 2" campaign to encourage people to take two minutes to learn the causes of, warning signs for and treatment for stroke and then take two minutes to tell two people about what youve learned. This sharing of information is important, as stroke can affect anyone at any age. Children can have strokes, people under 40 can have strokes, and one in 5 women have strokes, while 1 in 6 men can have strokes, Turco said. Even though one specific patient group is not at a higher risk, some conditions can increase your chances of a stroke. The most common risk factors include: - Alcohol consumption - Diabetes - … Continue reading →